SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-042941
Filing Date
2017-02-14
Accepted
2017-02-14 14:25:56
Documents
1
Group Members
BLACKSTONE CAPITAL PARTNERS V L.P.BLACKSTONE GROUP L.P.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HEALTHCARE PARTNERS L.L.C.BLACKSTONE HOLDINGS III GP L.P.BLACKSTONE HOLDINGS III GP MANAGEMENT L.L.C.BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C.BMA V L.L.C.S

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G d235343dsc13ga.htm SC 13G/A 155375
  Complete submission text file 0001193125-17-042941.txt   157316
Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Holdings III L.P. (Filed by) CIK: 0001404073 (see all company filings)

IRS No.: 260288853 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Subject) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-88544 | Film No.: 17607089
SIC: 2834 Pharmaceutical Preparations